PMID: 2004605
464,465,466,467,468 These GLP-1 receptor agonists can suppress the inflammatory response of macrophages, thereby inhibiting IR
Many patients see steady progress within the first month and continue losing weight safely and consistently over time
For chronic weight management, both trizepatide (Zepbound) and semaglutide 2.4 mg (Wegovy) are indicated for adults with a BMI 30 or a BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, type 2 diabetes, sleep apnea, or cardiovascular disease)
6 , eaax8214 (2020)
This article covers the mechanics, the economics, and the IP architecture of the bio-better category, why the model is attracting capital that used to flow toward biosimilar programs, and what the shift means for companies across the biologic supply chainfrom large-cap originators managing the Keytruda patent cliff to mid-tier developers deciding whether to build a biosimilar pipeline or a next-generation molecule